Dow Down0.25% Nasdaq Down0.26%

Anthera Pharmaceuticals, Inc. (ANTH)

2.52 0.04(1.56%) Aug 28, 4:00PM EDT
ProfileGet Profile for:
Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States - Map
Phone: 510-856-5600
Fax: 510-856-5597

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:25

Business Summary 

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. It is developing blisibimod, a Phase III product candidate that targets elevated levels of B-cell activating factor associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, IgA nephropathy, lupus nephritis, multiple myeloma, vasculitis, idiopathic thrombocytopenia purpura, and others. The company was founded in 2004 and is headquartered in Hayward, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Anthera Pharmaceuticals, Inc.

Key Executives 
Mr. Paul F. Truex MBA, 45
Chief Exec. Officer, Pres and Director
Ms. May Liu , 38
Sr. VP of Fin. & Admin., Principal Accounting Officer and Compliance Officer
Dr. Debra Odink Ph.D., 50
Chief Technology Officer and Sr. VP
Dr. Colin Hislop M.D., 56
Chief Medical Officer and Sr. VP
Dr. Paul Adams Ph.D., 51
Sr. VP of Global Regulatory Affairs and Compliance
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders